I read this article in a British newspaper: Medical experts furious that doctors will be paid to dole out ‘risky’ statins
… read on
It could mean four in 10 adults, including most of those in late middle age, are put on regular doses in a move that “medicalises” healthy people, leaving them at risk of side-effects including diabetes and memory loss.
Klim McPherson, professor of public health at Oxford University, said: “This
All around the country, and certainly in my own city (Seattle), hospital construction has been booming over the last ten years.
Billions of dollars are being spent, and not just for necessary upgrades. Hospitals are going for a more upscale look in the hopes that they can attract better paying patients (those with the best insurance coverage) and get better patient satisfaction scores.
And patient satisfaction scores are important because … read on
I’ve posted many times about the problems with the multi-billion-dollar supplement industry, and there was a good Op-Ed piece on Live Science yesterday that supported my own opinion: These 5 Supplements Do Nothing For Alzheimer’s, Despite Claims
The article was co-written by two physicians, both geriatric (aging) specialists.
… read on
The Latin axiom “caveat emptor,” let the buyer beware, applies to people of all ages. But in our medical practices, we have
More and more frequently I come across stories of patients who have inadvertently received care from “out-of-network” providers. And it can be a costly mistake.
When you are billed for the costs that your insurance company has denied, that’s called “balance billing.”
My insurance company doubles the deductible for out-of-network care; instead of $10,000, our deductible becomes $20,000. But insurance companies aren’t required by law to put a limit on … read on
I read a good post from a surgeon urging everyone to use good judgement when driving: Driving advice from a trauma surgeon
After my own stint in the OR of the local trauma center, I can attest to the fact that a seemingly minor bad decision when behind the wheel of a two-ton, fast-moving vehicle can result in horrific injuries. (Not to mention the financial cost is astronomical.)
The surgeon … read on
New drugs are expensive
Belsomra (suvorexant) is the newest sleeping pill to hit the market. If you think you might want to try it, or your physician suggests it, keep two things in mind.
As with any new and highly-marketed drug, it’s expensive, although not quite as costly as I thought it might be. According to GoodRx, a 30-day supply of 10mg tablets in my area code will cost on … read on
I read a lot of medical and nursing history, and I loved the Pulitzer-prize winning book “Emperor of All Maladies: A Biography of Cancer” by Siddhartha Mukherjee, MD, PhD.
So I was excited to find out that Ken Burns has produced a new PBS documentary based on the book. The six-hour special, Emperor … read on
A few days ago, Vox.com published an interview with Stanford researcher John Ioannidis, MD. Dr. Ioannidis is a meta-researcher, that is he researches research.
How accurate are research studies? How are they designed? How many subjects are involved? Can the results be duplicated? How do the results from one study compare with another?
These are the types of questions Dr. Ioannidis attempts to answer, as well as leading the effort … read on
I love this YouTube clip of John Oliver, The Daily Show alum and now host of his own HBO show, Last Week Tonight, in which he takes a humorous but scornful look at how Big Pharma markets drugs to doctors.
In 2013, we spent close to $330 billion on prescription medications; 70% of Americans take at least one prescription drug. As John Oliver … read on